Connecting you to content on EBSCOhost

Works matching AU Wu, Laing-You

Results: 4

1

Use of Sodium‐Glucose Transport Protein 2 Inhibitors and the Incidence of Urolithiasis: A Multi‐Database and Cross‐Country Study in Patients With Type 2 Diabetes Mellitus.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 6, p. 1775, doi. 10.1002/cpt.3626

By:

Chung, Mu‐Chi;
Lin, Chia‐Yen;
Chang, Chao‐Hsiang;
Chang, Yi‐Huei;
Hsiao, Po‐Jen;
Lien, Chi‐Shun;
Wu, Laing‐You;
Wu, Ming‐Ju;
Shieh, Jeng‐Jer;
Hung, Peir‐Haur;
Chen, Hsin‐Hua;
Chung, Chi‐Jung

Publication type:

Article

2

Association of Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and Incidence of Gout in Taiwan.

Published in:

JAMA Network Open, 2021, v. 4, n. 11, p. e2135353, doi. 10.1001/jamanetworkopen.2021.35353

By:

Chung, Mu-Chi;
Hung, Peir-Haur;
Hsiao, Po-Jen;
Wu, Laing-You;
Chang, Chao-Hsiang;
Wu, Ming-Ju;
Shieh, Jeng-Jer;
Chung, Chi-Jung

Publication type:

Article

3

Association of SGLT2 inhibitors with lower incidence of death in type 2 diabetes mellitus and causes of death analysis.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13760-7

By:

Chung, Mu-Chi;
Hsu, Hui-Tsung;
Chang, Chao-Hsiang;
Hung, Peir-Haur;
Hsiao, Po-Jen;
Wu, Laing-You;
Wu, Ming-Ju;
Shieh, Jeng-Jer;
Chung, Chi-Jung

Publication type:

Article

4

Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and the Incidence of Acute Kidney Injury in Taiwan.

Published in:

JAMA Network Open, 2023, v. 6, n. 2, p. e230453, doi. 10.1001/jamanetworkopen.2023.0453

By:

Chung, Mu-Chi;
Hung, Peir-Haur;
Hsiao, Po-Jen;
Wu, Laing-You;
Chang, Chao-Hsiang;
Hsiao, Kai-Yu;
Wu, Ming-Ju;
Shieh, Jeng-Jer;
Huang, Yu-Chuen;
Chung, Chi-Jung

Publication type:

Article